disulfiram has been researched along with Alcohol Problem in 28 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "A brief qualitative overview is given of previous and recent clinical studies on disulfiram in alcoholism treatment." | 3.77 | Supervised disulfiram in the treatment of alcohol use disorder: a commentary. ( Ehrenreich, H; Krampe, H; Spies, CD, 2011) |
| "The co-occurrence of PTSD and alcohol use disorder (AUD) is common." | 2.61 | [The pharmacological treatment of PTSD and alcohol use disorder: a systematic literature review]. ( de Jong, J; Neven, A; Pieterse, BH, 2019) |
| "Effective medications for treating alcohol use disorders (AUD) are available but underutilized." | 2.61 | Strategies to increase implementation of pharmacotherapy for alcohol use disorders: a structured review of care delivery and implementation interventions. ( Harris, AHS; Matson, TE; Williams, EC, 2019) |
| "Medications for treating alcohol dependence primarily have been adjunctive interventions, and only three medications--disulfiram, naltrexone, and acamprosate--are approved for this indication by the U." | 2.43 | Medications for treating alcohol dependence. ( Williams, SH, 2005) |
| "Disulfiram was the most commonly prescribed drug." | 1.48 | Use of drugs for alcohol use disorder in Norway 2004–16. ( Bramness, JG; Heldal, AT; Lobmaier, PPK; Skurtveit, S; Vederhus, JK, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (3.57) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (28.57) | 29.6817 |
| 2010's | 19 (67.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Neven, A | 1 |
| de Jong, J | 1 |
| Pieterse, BH | 1 |
| Lyon, J | 1 |
| Heldal, AT | 1 |
| Skurtveit, S | 1 |
| Lobmaier, PPK | 1 |
| Vederhus, JK | 1 |
| Bramness, JG | 2 |
| Williams, EC | 1 |
| Matson, TE | 1 |
| Harris, AHS | 1 |
| Zindel, LR | 1 |
| Kranzler, HR | 2 |
| Testino, G | 1 |
| Leone, S | 1 |
| Borro, P | 1 |
| Thibault, A | 1 |
| Brissette, S | 1 |
| Jutras-Aswad, D | 1 |
| Helton, SG | 1 |
| Lohoff, FW | 1 |
| Newton-Howes, G | 1 |
| Levack, WM | 1 |
| McBride, S | 1 |
| Gilmor, M | 1 |
| Tester, R | 1 |
| Brady, KT | 1 |
| Mann, K | 1 |
| Wurst, FM | 1 |
| Thamizh, JS | 1 |
| Menon, V | 1 |
| Selvakumar, N | 1 |
| Rajkumar, RP | 1 |
| Harris, AH | 1 |
| Bowe, T | 1 |
| Hagedorn, H | 1 |
| Nevedal, A | 1 |
| Finlay, AK | 1 |
| Gidwani, R | 1 |
| Rosen, C | 1 |
| Kay, C | 1 |
| Christopher, M | 1 |
| Krampe, H | 1 |
| Spies, CD | 1 |
| Ehrenreich, H | 1 |
| Jørgensen, CH | 1 |
| Pedersen, B | 1 |
| Tønnesen, H | 1 |
| Abraham, AJ | 1 |
| Knudsen, HK | 1 |
| Roman, PM | 1 |
| Spanagel, R | 1 |
| Vengeliene, V | 1 |
| Clark, DB | 1 |
| LESTER, D | 1 |
| CONWAY, EJ | 1 |
| MANN, NM | 1 |
| Kenna, GA | 1 |
| McGeary, JE | 1 |
| Swift, RM | 1 |
| Williams, SH | 1 |
| Swift, R | 1 |
| McDonough, KP | 1 |
| Peterson, AM | 1 |
| Green, AI | 1 |
| Drake, RE | 1 |
| Brunette, MF | 1 |
| Noordsy, DL | 1 |
| Soyka, M | 1 |
| Berglund, M | 1 |
| Gorelick, D | 1 |
| Hesselbrock, V | 1 |
| Johnson, BA | 1 |
| Möller, HJ | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Lemborexant Augmentation of Naltrexone for Alcohol Craving and Sleep: A Randomized, Double-Blind, Placebo- Controlled Study[NCT05458609] | Phase 3 | 14 participants (Anticipated) | Interventional | 2023-02-09 | Enrolling by invitation | ||
| Treatment for Alcohol Dependence With Gabapentin: A Double Blind Placebo Controlled Randomized Clinical Trial[NCT02771925] | Phase 4 | 25 participants (Actual) | Interventional | 2016-06-30 | Terminated (stopped due to Due to poor compliance of patients in the study.) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
13 reviews available for disulfiram and Alcohol Problem
| Article | Year |
|---|---|
[The pharmacological treatment of PTSD and alcohol use disorder: a systematic literature review].
Topics: Alcohol-Related Disorders; Disulfiram; Drug Therapy, Combination; Humans; Naltrexone; Randomized Con | 2019 |
Strategies to increase implementation of pharmacotherapy for alcohol use disorders: a structured review of care delivery and implementation interventions.
Topics: Acamprosate; Alcohol Deterrents; Alcohol-Related Disorders; Alcoholism; Clinical Trials as Topic; Di | 2019 |
Pharmacotherapy of alcohol use disorders: seventy-five years of progress.
Topics: Acamprosate; Alcohol Deterrents; Alcohol-Related Disorders; Disulfiram; Fructose; Humans; Hypnotics | 2014 |
Treatment of alcohol dependence: recent progress and reduction of consumption.
Topics: Acamprosate; Age of Onset; Alcohol Deterrents; Alcohol-Related Disorders; Alcoholism; Binge Drinking | 2014 |
Systematic review of the pharmacological treatment of alcohol use disorders in individuals infected with hepatitis C.
Topics: Alcohol Deterrents; Alcohol-Related Disorders; Baclofen; Disulfiram; Hepatitis C; Humans; Transamina | 2015 |
Pharmacogenetics of alcohol use disorders and comorbid psychiatric disorders.
Topics: Acamprosate; Alcohol Deterrents; Alcohol-Related Disorders; Anxiety Disorders; Comorbidity; Depressi | 2015 |
The efficacy of disulfiram for the treatment of alcohol use disorder.
Topics: Adolescent; Adult; Aged; Alcohol Deterrents; Alcohol-Related Disorders; Alcoholism; Central Nervous | 2011 |
New pharmacological treatment strategies for relapse prevention.
Topics: Acamprosate; Alcohol Deterrents; Alcohol-Related Disorders; Animals; Disulfiram; Drugs, Investigatio | 2013 |
Pharmacotherapy, pharmacogenomics, and the future of alcohol dependence treatment, part 1.
Topics: Acamprosate; Alcohol Deterrents; Alcohol Drinking; Alcohol-Related Disorders; Animals; Clinical Tria | 2004 |
Medications for treating alcohol dependence.
Topics: Acamprosate; Adult; Aged; Alcohol Deterrents; Alcohol-Related Disorders; Alcoholism; Disulfiram; Dos | 2005 |
Emerging approaches to managing alcohol dependence.
Topics: Acamprosate; Alcohol Deterrents; Alcohol-Related Disorders; Behavior Therapy; Brain; Disulfiram; Dru | 2007 |
Improving adherence in patients with alcohol dependence: a new role for pharmacists.
Topics: Acamprosate; Alcohol Deterrents; Alcohol-Related Disorders; Behavior Therapy; Disulfiram; Humans; Na | 2007 |
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Substance Use and Related Disorders, Part 1: Alcoholism.
Topics: Acamprosate; Alcohol Deterrents; Alcohol-Related Disorders; Biological Psychiatry; Carbamazepine; Di | 2008 |
15 other studies available for disulfiram and Alcohol Problem
| Article | Year |
|---|---|
More Treatments on Deck for Alcohol Use Disorder.
Topics: Acamprosate; Alcohol Deterrents; Alcohol-Related Disorders; Amines; Baclofen; Cyclohexanecarboxylic | 2017 |
Use of drugs for alcohol use disorder in Norway 2004–16.
Topics: Acamprosate; Adult; Alcohol Deterrents; Alcohol-Related Disorders; Disulfiram; Drug Prescriptions; D | 2018 |
KASL clinical practice guidelines: management of alcoholic liver disease.
Topics: Alcohol Abstinence; Alcohol Drinking; Alcohol-Related Disorders; Baclofen; Disulfiram; Fatty Liver, | 2013 |
Non-physiological mechanisms influencing disulfiram treatment of alcohol use disorder: A grounded theory study.
Topics: Adult; Alcohol-Related Disorders; Disulfiram; Female; Grounded Theory; Humans; Male; Middle Aged | 2016 |
Old dog, new tricks: treating co-occurring anxiety and alcohol use disorders.
Topics: Alcohol-Related Disorders; Alcoholism; Anxiety; Anxiety Disorders; Disulfiram; Humans; Lorazepam; Pi | 2016 |
Marketing Status and Perceived Efficacy of Drugs for Supporting Abstinence and Reducing Alcohol Intake in Alcohol Use Disorders: A Survey among European Federation of Addiction Societies in Europe.
Topics: Acamprosate; Alcohol Abstinence; Alcohol Deterrents; Alcohol-Related Disorders; Disulfiram; Europe; | 2016 |
Treatment-Emergent Psychosis With Disulfiram in a Patient With Late-Onset Alcohol Use Disorder and No Contributory Factors.
Topics: Age of Onset; Alcohol Deterrents; Alcohol-Related Disorders; Disulfiram; Humans; Male; Middle Aged; | 2016 |
Multifaceted academic detailing program to increase pharmacotherapy for alcohol use disorder: interrupted time series evaluation of effectiveness.
Topics: Acamprosate; Adult; Alcohol Deterrents; Alcohol-Related Disorders; Disulfiram; Female; Fructose; Hum | 2016 |
Alcohol dependence: after the withdrawal phase. Long-term abstinence: better health and psychosocial status. Psychosocial support for a chronic disorder. Some drugs are useful adjuncts to medical support.
Topics: Acamprosate; Alcohol Deterrents; Alcohol Drinking; Alcohol-Related Disorders; Alcoholics; Alcoholism | 2009 |
Supervised disulfiram in the treatment of alcohol use disorder: a commentary.
Topics: Alcohol Deterrents; Alcohol-Related Disorders; Alcoholism; Disulfiram; Female; Humans; Male; Seconda | 2011 |
A longitudinal examination of alcohol pharmacotherapy adoption in substance use disorder treatment programs: patterns of sustainability and discontinuation.
Topics: Alcohol Deterrents; Alcohol-Related Disorders; Alcoholism; Databases, Factual; Disulfiram; Drug Util | 2011 |
Pharmacotherapy for adolescent alcohol use disorder.
Topics: Acamprosate; Adolescent; Alcohol-Related Disorders; Antidepressive Agents; Attention Deficit Disorde | 2012 |
Evaluation of antidotes for the alcohol reaction syndrome in patients treated with disulfiram (tetraethylthiuram disulfide).
Topics: Alcohol-Related Disorders; Alcohols; Antidotes; Disulfiram; Iron Compounds | 1952 |
Alcohol dependence and pharmacologic treatment. Introduction.
Topics: Acamprosate; Alcohol Deterrents; Alcohol-Related Disorders; Disulfiram; Humans; Naltrexone; Taurine; | 2007 |
Schizophrenia and co-occurring substance use disorder.
Topics: Acamprosate; Adult; Alcohol-Related Disorders; Antipsychotic Agents; Comorbidity; Diagnosis, Dual (P | 2007 |